De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism.
De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism.
复制标题
DOI:
10.1101/mcs.a002097
复制
发表时间:
2017-11
影响因子:
1.8
通讯作者:
Chung WK
中科院分区:
文献类型:
--
作者:
Tanaka AJ;Cho MT;Willaert R;Retterer K;Zarate YA;Bosanko K;Stefans V;Oishi K;Williamson A;Wilson GN;Basinger A;Barbaro-Dieber T;Ortega L;Sorrentino S;Gabriel MK;Anderson IJ;Sacoto MJG;Schnur RE;Chung WK
Using whole-exome sequencing, we identified seven unrelated individuals with global developmental delay, hypotonia, dysmorphic facial features, and an increased frequency of short stature, ataxia, and autism with de novo heterozygous frameshift, nonsense, splice, and missense variants in the Early B-cell Transcription Factor Family Member 3 (EBF3) gene. EBF3 is a member of the collier/olfactory-1/early B-cell factor (COE) family of proteins, which are required for central nervous system (CNS) development. COE proteins are highly evolutionarily conserved and regulate neuronal specification, migration, axon guidance, and dendritogenesis during development and are essential for maintaining neuronal identity in adult neurons. Haploinsufficiency of EBF3 may affect brain development and function, resulting in developmental delay, intellectual disability, and behavioral differences observed in individuals with a deleterious variant in EBF3.